NEW YORK (GenomeWeb News) – Amyris said today that it has received a contract from the US Department of Defense Advanced Research Projects Agency that could total around $8 million to expand the scope of its synthetic biology technology across new biological platforms and cell types.

DARPA awarded the contract in connection with its Living Foundries Program, which seeks to create the fundamental production methods and tools, technologies, and methods required to make bio-engineering better, faster, and more accurate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.